Strategic Growth Emerging pipeline toward external and in-office stone interventions indicates potential cross-sell opportunities to endourology clinics, ambulatory surgery centers, and urology practices seeking minimally invasive stone management.

Financial Traction With current revenue between one and ten million and a modest funding round, PercSys may be positioned to scale sales teams and accelerate adoption through targeted clinical partnerships and pilot programs.

Healthcare Partnerships Align with large medical device ecosystems and OEMs in the urology and imaging space to leverage distribution networks, clinical education, and bundled offerings that enhance device adoption.

Clinical Differentiation Emphasize less traumatic, more effective endourologic procedures to position PercSys as a value-added solution for performance-improving outcomes in stone disease management, supporting requests from hospitals pursuing quality metrics.

Technology & Data Leverage cloud-enabled capabilities and web presence to support remote monitoring, post-market surveillance, and evidence generation collaborations with research centers and medical centers.